Conventional influenza vaccination compared to MF59 adjuvanted subunit vaccine

被引：0
|
作者：
Torrecilla Rojas, Maria Amparo [1 ]
Pedregal Gonzalez, Miguel [2 ]
Garcia Rodriguez, Fermin [3 ]
Ruiz Fernandez, Josefa [3 ]
机构：
[1] Unidad Salud Publ, Dist Sanitario Condado C, Huelva, Spain
[2] Unidad Docente Med Familiar & Comunitaria, Dist Sanitario Huelva Co, Huelva, Spain
[3] Consejeria Salud Junta Andalucia, Secretaria Gen Salud Publ & Participac, Seville, Spain
来源：
ATENCION PRIMARIA | 2009年 / 41卷 / 12期
关键词：
ELDERLY SUBJECTS; IMMUNOGENICITY; SPLIT; PROTECTION; SAFETY; VIRUS; REACTOGENICITY; PNEUMONIA; AGE;
D O I：
10.1016/j.aprim.2009.06.008
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：695 / 697
页数：3
相关论文
共 50 条
  • [41] Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly
    Ruf, BR
    Colberg, K
    Frick, M
    Preusche, A
    INFECTION, 2004, 32 (04) : 191 - 198
  • [42] Immunogenicity and protective efficacy in dogs of an MF59™-adjuvanted vaccine against recombinant canine/porcine coronavirus
    Decaro, Nicola
    Mari, Viviana
    Sciarretta, Rossana
    Colao, Valeriana
    Losurdo, Michele
    Catella, Cristiana
    Elia, Gabriella
    Martella, Vito
    Del Giudice, Giuseppe
    Buonavoglia, Canio
    VACCINE, 2011, 29 (11) : 2018 - 2023
  • [43] MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
    Higgins, DA
    Carlson, JR
    VanNest, G
    VACCINE, 1996, 14 (06) : 478 - 484
  • [44] Open, Randomized Study to Compare the Immunogenicity and Reactogenicity of an Influenza Split Vaccine with an MF59-Adjuvanted Subunit Vaccine and a Virosome-Based Subunit Vaccine in Elderly
    B. R. Ruf
    K. Colberg
    M. Frick
    A. Preusche
    Infection, 2004, 32 : 191 - 198
  • [45] Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin
    Drulak, MW
    Malinoski, FJ
    Fuller, SA
    Stewart, SS
    Hoskin, S
    Duliege, AM
    Sekulovich, R
    Burke, R
    Winston, S
    VIRAL IMMUNOLOGY, 2000, 13 (01) : 49 - 56
  • [46] Relative Effectiveness of the MF59®-Adjuvanted Influenza Vaccine Versus High-Dose and Non-Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During the 2019-2020 US Influenza Season
    Imran, Mahrukh
    Puig-Barbera, Joan
    Ortiz, Justin R.
    Lopez-Gonzalez, Lorena
    Dean, Alex
    Bonafede, Machaon
    Haag, Mendel D. M.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (04)
  • [47] MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
    El Sahly, Hana
    EXPERT REVIEW OF VACCINES, 2010, 9 (10) : 1135 - 1141
  • [48] Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
    de Bruijn, Iris
    Meyer, Ingo
    Gerez, Lisya
    Nauta, Jos
    Giezeman, Katinka
    Palache, Bram
    VACCINE, 2007, 26 (01) : 119 - 127
  • [49] Randomized Trial of a MF-59 Adjuvanted Influenza Vaccine in Kidney Transplant Recipients
    Kumar, D.
    Campbell, P.
    Hidalgo, L.
    Hoschler, K.
    Al-Dabbagh, M.
    Humar, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 767 - 768
  • [50] Randomized Trial of a MF-59 Adjuvanted Influenza Vaccine in Kidney Transplant Recipients
    Kumar, D.
    Campbell, P.
    Hidalgo, L.
    Hoschler, K.
    Al-Dabbagh, M.
    Humar, A.
    TRANSPLANTATION, 2014, 98 : 767 - 768
12345